ClinicalTrials.gov
ClinicalTrials.gov Menu

Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00170001
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : December 15, 2011
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Mayo Clinic

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2006
  Actual Study Completion Date : August 2006